PKM and cancer: PKM2 mainly includes two configurations, namely dimer and tetramer, and is mainly presented as dimer in cancer cells, where it facilitates the production of nucleic acid and protein as well as maintaining the aerobic glycolytic pathway (Liu et al., 2014; Yoon et al., 2018), as a result, PKM2 is expected to be a therapeutic target for various cancers.